CareDx, Inc. (CDNA) analyst actions
Rating and price-target actions on CDNA in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the CDNA overview →
1 measured CDNA analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| CareDx Reiterates Position that it Does Not Infringe the ‘544 Patent, Injunction Motion is Irrelevant | Press release | -3.88% | -12.86% |
Keep exploring
More CDNA: earnings → · SEC filings → · CDNA overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Cosmos Health Inc. (COSM) | 450 | 0.00% | 50% |
| ROCHE HOLDING LTD S/ADR (RHHBY) | 449 | +0.03% | 52% |
| Arvinas, Inc. (ARVN) | 442 | -0.26% | 42% |
| Jaguar Health, Inc. (JAGX) | 442 | -0.38% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.